Provided by Tiger Trade Technology Pte. Ltd.

OPKO Health

1.12
-0.0500-4.27%
Post-market: 1.120.00000.00%19:59 EDT
Volume:3.47M
Turnover:3.95M
Market Cap:850.16M
PE:-3.73
High:1.18
Open:1.15
Low:1.12
Close:1.17
52wk High:1.75
52wk Low:1.10
Shares:759.07M
Float Shares:339.00M
Volume Ratio:0.93
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3005
EPS(LYR):-0.3005
ROE:-17.14%
ROA:-6.62%
PB:0.67
PE(LYR):-3.73

Loading ...

Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook?

Simply Wall St.
·
Nov 20, 2025

U.S. RESEARCH ROUNDUP-Agios Pharmaceuticals, Dycom, Lowe's

Reuters
·
Nov 20, 2025

OPKO Health Inc : JP Morgan Initiates Coverage With Neutral Rating

THOMSON REUTERS
·
Nov 20, 2025

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire
·
Nov 20, 2025

Opko Health CEO Phillip Frost Reports Acquisition of Common Shares

Reuters
·
Nov 19, 2025

Entera Bio reports Q3 net loss of $3.2 million

Reuters
·
Nov 15, 2025

Press Release: NextPlat Reports Third Quarter 2025 Results

Dow Jones
·
Nov 13, 2025

OPKO Health (OPK): Evaluating Valuation After Oncology Business Sale and Updated Earnings Guidance

Simply Wall St.
·
Nov 12, 2025

Is OPKO Health's Post-Oncology Revenue Guidance Reset Shifting the Investment Case for OPK?

Simply Wall St.
·
Nov 10, 2025

OPKO Health (OPK) Is Down 9.3% After Regeneron Collaboration and Asset Sale Announcement – Has the Bull Case Changed?

Simply Wall St.
·
Nov 01, 2025

Opko Health CEO and Chairman Phillip Frost Reports Acquisition of Common Shares

Reuters
·
Nov 01, 2025

OPKO Health Shares Fall After Jefferies Downgrade

MT Newswires Live
·
Nov 01, 2025

Stock Track | OPKO Health Plummets 5.14% Following Jefferies Downgrade and Price Target Cut

Stock Track
·
Nov 01, 2025

OPKO Health Cut to Hold From Buy by Jefferies

Dow Jones
·
Nov 01, 2025

Jefferies Downgrades OPKO Health to Hold From Buy, Adjusts Price Target to $1.60 From $2

MT Newswires Live
·
Oct 31, 2025

OPKO Health Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $1.6 From $2

THOMSON REUTERS
·
Oct 31, 2025

OPKO Health Is Maintained at Outperform by Barrington Research

Dow Jones
·
Oct 30, 2025

Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK)

TIPRANKS
·
Oct 30, 2025

Healthcare firm OPKO's Q3 revenue falls

Reuters
·
Oct 30, 2025

BRIEF-OPKO Health Q3 Net Income USD 21.6 Million

Reuters
·
Oct 30, 2025